Midgard Science

Labs / CDMO: development & manufacturing

Aarti Pharmalabs Limited

Mumbai, India · aartipharmalabs.com

Aarti Pharmalabs Limited develops and manufactures APIs, NCEs, HPAPIs, peptides, oligos, payload-linker conjugates, intermediates, RSMs, KSMs, and key building blocks for clinical development and commercial production. It serves pharmaceutical and biotechnology companies from sites in Gujarat and Maharashtra, India, with products exported to regulated markets including the USA, the European Union, and Japan.

They take quote requests by email.

What they offer

  • Small Molecules CDMO

    Provides end-to-end CMC services for critical drug substances from laboratory benchwork and pilot scale through clinical trials, launch, and commercial manufacturing.

  • Peptides & Oligos (TIDES)

    Develops and manufactures peptide and oligonucleotide programs as part of its CDMO offering.

  • Payload-Linker Conjugates

    Supports development and manufacturing of payload-linker conjugates, including dedicated OEB-6 laboratory expansion.

  • HPAPIs

    Develops and manufactures highly potent APIs with containment capabilities in dedicated facilities.

  • Flow Chemistry

    Uses flow chemistry capabilities to support process development and scale-up.

  • Route Scouting

    Supports CMC development by identifying and evaluating synthetic routes.

  • Process R&D

    Performs process research and development for optimization and scale-up of drug substance processes.

  • Technology Transfer

    Transfers developed processes into manufacturing for clinical and commercial production.

  • Validation

    Supports validation activities for processes moving into commercial manufacturing.

  • Commercial Manufacturing

    Manufactures APIs, intermediates, and drug substances at commercial scale.

What they work on

Modalities
Small molecule, Peptide, Oligonucleotide
Assays and studies
salt screening, polymorph studies, stability studies, analytical development, process safety
Instruments and platforms
flow reactors, autoclaves, fume hoods
Scale and capacity
450 KL/M³ manufacturing capacity at Atali, approximately 31,200 litres reactor capacity at Dombivli, 100 MT per month caffeine production capacity at Unit 5, 5,000 TPA xanthine capacity
Type
CDMO
Sites
Mumbai, India · Navi Mumbai, India · Dombivli, India · Tarapur, India · Vapi, India · Atali, India
Team
2400+ Employees
Quality
ISO/IEC 27001:2022 (CDMO R&D Nerul) · USFDA (Dombivli Unit) · USFDA (Tarapur Unit 4) · EUGMP (Tarapur Unit 4) · ANVISA (Tarapur Unit 4) · EDQM (Oncology block at Unit 4) · Cofepris (Unit 4)
Serves
USA, European Union, Japan, global
Founded
2022

Public records

FDA establishment
3005256484
FDA drug establishment
AARTI PHARMALABS LIMITED source
FDA drug establishment registration
3005256484 · API MANUFACTURE source

Similar labs. Enantia, Porton, SmaBio Labs, WuXi STA

Found in a contract services directory. Listing built from aartipharmalabs.com. Work here? Claim this listing.

Aarti Pharmalabs Limited · Midgard Science